Diversion and Abuse of Buprenorphine

Office of Applied Studies (2006a). The DAWN Report: . Emergency Department Visits Involving
Nonmedical Use of Selected Pharmaceuticals. Rockville, MD: Substance Abuse and Mental
Health Services Administration, Issue 23.
Office of Applied Studies (2006b). The DASIS Report: Non-Heroin Opiate Admissions: 2003.
Rockville, MD: Substance Abuse and Mental Health Services Administration, Issue 14.
Office of Applied Studies (2005). Treatment Episode Data Set (TEDS) Report: Admission to
Treatment Programs, 2004. Rockville, MD: Substance Abuse and Mental Health Services
Administration.
Office of National Drug Control Policy (ONDCP) (2004). National Drug Control Strategy.
Washington, DC: Executive Office of the President, The White House, pp. 22-35.
Raisch DW, Fudala PJ, Saxon AJ et al. (2005). Pharmacists’ and technicians’ perceptions and
attitudes toward dispensing buprenorphine/naloxone to patients with opioid dependence.
Journal of the American Pharmacists Association 45(1):23-32.
Ray R, Pal H, Kumar R et al. (2004). Post-marketing surveillance of buprenorphine.
Pharmacoepidemiology and Drug Safety Sep;13(9):615-619.
Robinson GM, Dukes PD, Robinson BJ et al. (1993). The misuse of buprenorphine and a
buprenorphine-naloxone combination in Wellington, New Zealand. Drug and Alcohol
Dependence Jun;33(1):81-86.
Rudolf PM & Bernstein IBG (2004). Counterfeit drugs. New England Journal of Medicine
350:1384-1386.
Substance Abuse and Mental Health Services Administration (2005). Results from the 2004
National Survey on Drug Use and Health: National Findings (Office of Applied Studies,
NSDUH Series H-28, DHHS Publication No. SMA 05-4062). Rockville, MD. Tables 1.1A and
1.129A downloaded from http://oas.samhsa.gov on March 4, 2006.
Substance Abuse and Mental Health Services Administration (2002). Summary of Findings from
the 2001 National Household Survey on Drug Abuse: Volume II. Technical Appendices and
Selected Data Tables (Office of Applied Studies, DHHS Pub. No. SMA 02-3759). Rockville,
MD: Substance Abuse and Mental Health Services Administration.
Saxon AJ & McCarty D (2005). Challenges in the adoption of new pharmacotherapeutics for
addiction to alcohol and other drugs. Pharmacologic Therapies 108(1):119-128.
Sporer KA (2004). Buprenorphine: A primer for emergency physicians. Annals of Emergency
Medicine 43(5):580-584.
Stein MD, Cioe P & Friedmann PD (2005). Buprenorphine retention in primary care. Journal of
General Internal Medicine 20(11):1038-1041.
Buprenorphine Assessment: Final Report 21